 AUSTIN, Texas, Feb. 03, 2021 GLOBE NEWSWIRE -- Aspira Womens Health Inc. Nasdaq: AWH Aspira, a bio-analytical based womens health company focused on gynecologic disease, today announced it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Aspira is expected to grant the underwriters a 30-day option to purchase up to an additional 15 of the shares of common stock being offered at the public offering price, less underwriting discounts and commissions. All of the shares will be offered by Aspira. 